Brandon May

Fractional exhaled nitric oxide values may help in the identification of cough variant asthma in patients with chronic cough.

Mepolizumab was associated with reductions in eosinophil levels and asthma exacerbations,
as well as improvements in quality of life in uncontrolled severe eosinophilic asthma.

Budesonide oral suspension was associated with improvements in dysphagia in patients with eosinophilic esophagitis.

Antiphospholipid antibodies were associated with the presence of food allergies.

The oral plasma kallikrein inhibitor, BCX7353, reduced hereditary angioedema attacks during a 24-week treatment period.

Use of home oxygen is associated with reduced physical function in patients with either COPD or idiopathic pulmonary fibrosis.

Combination therapy consisting of once-daily macitentan and tadalafil was associated with reductions in pulmonary vascular resistance in patients with pulmonary arterial hypertension.

Twice-daily ensifentrine was associated with improvements in several symptoms of COPD, including breathlessness, chest symptoms, cough and sputum, and shortness of breath.

Clinical experts in pulmonary arterial hypertension (PAH) identified certain hemodynamic variables as predictive of patient survival that were different from variables found in major clinical trials.

Twice-daily selexipag was associated with improvements in 6-minute walk distance and potential maintenance or improvement in World Health Organization functional class in patients with pulmonary arterial hypertension.